Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases;A mikro-RNS-ek szerepe a gyulladásos bélbetegségek diagnosztikájában

Orvosi Hetilap

Volumn 155, Issue 13, 2014, Pages 487-491

  Igaz, Iván ^a   Szonyi, Mihály ^a   Varga, Patrícia ^a   Topa, Lajos ^a  

^a Szent Imre Egyetemi Oktatokorhaz Gasztroenterologia Profil Budapest Tetenyi Ut 12 16 1115 ^*  (Hungary)

Author keywords

biomarker; inflammatory bowel disease; microRNA

Indexed keywords

MICRORNA;

ARTICLE; INFLAMMATORY BOWEL DISEASE; PATHOGENESIS; PROTEIN EXPRESSION;

BIOMARKER; GYULLADÁSOS BÉLBETEGSÉG; INFLAMMATORY BOWEL DISEASE; MICRORNA; MIKRO-RNS;

AUTOIMMUNITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MICRORNAS;

EID: 84896918740     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2014.29864     Document Type: Article

References (47)

1. Glocker, E., Grimbacher, B.: Inflammatory bowel disease: is it a primary immunodeficiency? Cell. Mol. Life Sci., 2012, 69(1), 41-48.
2. Nielsen, O. H., Rask-Madsen, J.: Mediators of inflammation in chronic inflammatory bowel disease. Scand. J. Gastroenterol. Suppl., 1996, 216, 149-159. (Pubitemid 26129313)
3. Maloy, K. J., Powrie, F.: Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature, 2011, 474(7351), 298-306.
4. Tsianos, E. V., Katsanos, K. H., Tsianos, V. E.: Role of genetics in the diagnosis and prognosis of Crohn's disease. World J. Gastroenterol., 2012, 18(2), 105-118.
5. Bartel, D. P.: MicroRNAs: target recognition and regulatory functions. Cell, 2009, 136(2), 215-233.
6. Filipowicz, W., Bhattacharyya, S. N., Sonenberg, N.: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet., 2008, 9(2), 102-114.
7. Faraoni, I., Antonetti, F. R., Cardone, J., et al.: miR-155 gene: a typical multifunctional microRNA. Biochim. Biophys. Acta, 2009, 1792(6), 497-505.
8. Negrini, M., Nicoloso, M. S., Calin, G. A.: MicroRNAs and cancer-New paradigms in molecular oncology. Curr. Opin. Cell Biol., 2009, 21(3), 470-479.
9. Aslam, M. I., Taylor, K., Pringle, J. H., et al.: MicroRNAs are novel biomarkers of colorectal cancer. Br. J. Surg., 2009, 96(7), 702-710.
10. Xi, Y., Formentini, A., Chien, M., et al.: Prognostic values of microRNAs in colorectal cancer. Biomark. Insights, 2006, 1, 113-121.
11. Altomare, D. F., Di Lena, M., Giuratrabocchetta, S.: MicroRNA: future perspectives in colorectal cancer. Colorectal Dis., 2012, 14(2), 133-134.
12. Li, A., Yu, J., Kim, H., et al.: MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin. Cancer Res., 2013, 19(13), 3600-3610.
13. Kawaguchi, T., Komatsu, S., Ichikawa, D., et al.: Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer. Br. J. Cancer, 2013, 108(2), 361-369.
14. Zhong, X. Y., Yu, J. H., Zhang, W. G., et al.: MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene, 2012, 493(1), 44-51.
15. Zhang, J., Han, C., Wu, T.: MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin. Gastroenterology, 2012, 143(1), 246-256.e8.
16. Shigehara, K., Yokomuro, S., Ishibashi, O., et al.: Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One, 2011, 6(8), e23584.
17. Calin, G. A., Croce, C. M.: MicroRNA signatures in human cancers. Nat. Rev. Cancer, 2006, 6(11), 857-866. (Pubitemid 44629897)
18. O'Connell, R. M., Rao, D. S., Baltimore, D.: microRNA regulation of inflammatory responses. Annu. Rev. Immunol., 2012, 30, 295-312.
19. Sun, X., Sit, A., Feinberg, M. W.: Role of miR-181 family in regulating vascular inflammation and immunity. Trends Cardiovasc. Med., 2013 Oct 31. [Epub ahead of print]
20. Banerjee, S., Cui, H., Xie, N., et al.: miR-125a-5p regulates differential activation of macrophages and inflammation. J. Biol. Chem., 2013, 288(49), 35428-35436.
21. Paraboschi, E. M., Soldà, G., Gemmati, D., et al.: Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. Int. J. Mol. Sci., 2011, 12(12), 8695-8712.
22. Singh, R. P., Massachi, I., Manickavel, S., et al.: The role of miRNA in inflammation and autoimmunity. Autoimmun. Rev., 2013, 12(12), 1160-1165.
23. Jimenez, S. A., Piera-Velazquez, S.: Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome. Autoimmun. Rev., 2013, 12(11), 1046-1051.
24. Pauley, K. M., Satoh, M., Chan, A. L., et al.: Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther., 2008, 10(4), R101.
25. Sonkoly, E., Wei, T., Janson, P. C., et al.: MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One, 2007, 2(7), e610.
26. Igaz, I., Topa, L.: Significance of microRNA expression in body fluids in the diagnosis of gastrointestinal tumors. [A testváladékok mikro-RNS-kifejezodésének jelentosége a gyomor-bél rendszeri tumorok diagnosztikájában.] Orv. Hetil., 2014, 155(1), 11-15. [Hungarian]
27. Biton, M., Levin, A., Slyper, M., et al.: Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. Nat. Immunol., 2011, 12(3), 239-246.
28. Wu, F., Zikusoka, M., Trindade, A., et al.: MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology, 2008, 135(5), 1624-1635.e24.
29. Bian, Z., Li, L., Cui, J., et al.: Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J. Pathol., 2011, 225(4), 544-553.
30. Wu, F., Zhang, S., Dassopoulos, T., et al.: Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm. Bowel Dis., 2010, 16(10), 1729-1738.
31. Takagi, T., Naito, Y., Mizushima, K., et al.: Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J. Gastroenterol. Hepatol., 2010, 25(Suppl. 1), S129-S133.
32. O'Connell, R. M., Kahn, D., Gibson, W. S., et al.: MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity, 2010, 33(4), 607-619.
33. Fasseu, M., Tréton, X., Guichard, C.: Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One, 2010, 5(10), e13160.
34. He, H., Jazdzewski, K., Li, W., et al.: The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl Acad. Sci. USA, 2005, 102(52), 19075-19080. (Pubitemid 43049568)
35. Nguyen, H. T., Dalmasso, G., Yan, Y., et al.: MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. J. Biol. Chem., 2010, 285(2), 1479-1489.
36. Pekow, J. R., Dougherty, U., Mustafi, R., et al.: miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm. Bowel Dis., 2012, 18(1), 94-100.
37. Chen, Y., Wang, C., Liu, Y., et al.: miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn's disease. Biochem. Biophys. Res. Commun., 2013, 438(1), 133-139.
38. Koukos, G., Polytarchou, C., Kaplan, J. L., et al.: MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology, 2013, 145(4), 842-852.e2.
39. Nata, T., Fujiya, M., Ueno, N., et al.: MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function. J. Gene Med., 2013, 15(6-7), 249-260.
40. Maharshak, N., Shenhar-Tsarfaty, S., Aroyo, N., et al.: MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm. Bowel Dis., 2013, 19(7), 1346-1353.
41. Zahm, A. M., Thayu, M., Hand, N. J., et al.: Circulating microRNA is a biomarker of pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr., 2011, 53(1), 26-33.
42. Paraskevi, A., Theodoropoulos, G., Papaconstantinou, I., et al.: Circulating microRNA in inflammatory bowel disease. J. Crohns Colitis, 2012, 6(9), 900-904.
43. Duttagupta, R., DiRienzo, S., Jiang, R., et al.: Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis. PLoS One, 2012, 7(2), e31241.
44. Olaru, A. V., Yamanaka, S., Vazquez, C., et al.: MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease. Inflamm. Bowel Dis., 2013, 19(3), 471-480.
45. Zhang, G. J., Zhou, H., Xiao, H. X., et al.: Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer. Cancer Cell Int., 2013, 13(1), 104.
46. De Iudicibus, S., Lucafo, M., Martelossi, S., et al.: MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. World J. Gastroenterol., 2013, 19(44), 7947-7954.
47. Shi, C., Liang, Y., Yang, J., et al.: MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury. PLoS One, 2013, 8(6), e66814.